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ABSTRAK 
Pendahuluan: Di Indonesia, resistensi terbesar pada uropatogen E. coli adalah resistensi terhadap ampisilin (91,9%), siprofloksasin 
(83,7%) dan sefiksim (67,6%). α-mangostin merupakan salah satu senyawa kimia yang dikembangkan sebagai antibiotik baru dari isolat 
herbal Garcinia mangostana L, namun belum terbukti efektifitasnya terhadap E. coli multiresisten. Tujuan: Penelitian ini menguji 
aktivitas α- mangostin secara in vitro pada pertumbuhan bakteri uropatogen E. coli multiresisten. 
Metode: Perlakuan terhadap bakteri uropatogen E. coli dilakukan secara in vitro, menggunakan α-mangostin menggunakan kadar 14; 
28,13; 56,25; 112,5; 225; dan 450 µg/mL dengan replikasi 4 kali pada masing-masing konsentrasi. Aktivitas antibakteri dari α-mangostin 
diukur dengan melihat pertumbuhan atau kematian bakteri pada setiap konsentrasi menggunakan metode tidak langsung, yaitu metode 
pembacaan absorbansi sampel. Sampel atau uropatogen E. coli yang telah diberi perlakuan berbagai dosis α-mangostin diinkubasi 
selama 18 – 20 jam, kemudian dibaca absorbansinya menggunakan spektrofotometer UV-Vis λ 625 nm. 
Hasil: Nilai Kadar Hambat Minimal (KHM) pada penelitian ini adalah 450 µg/mL. Berdasarkan uji regresi linear (STATA 13.1) 
hubungan konsentrasi α-mangostin dan aktivitas hambatan pertumbuhan bakteri, didapatkan nilai uji F 0,0001 < 0,05 menyatakan 
bahwa semua konsentrasi α-mangostin secara simultan mempunyai pengaruh signifikan terhadap pertumbuhan uropatogen E. coli.
Kesimpulan: α-mangostin tidak efektif untuk menghambat pertumbuhan bakteri uropatogen E. coli multiresisten karena nilai KHM 
450 µg/mL relatif besar. Aktivitas relevan berpotensi di klinik akan terjadi apabila nilai KHM suatu zat secara in vitro < 100 µg/mL. 
Bahkan industri farmasi lebih menyukai pengembangan antibiotik yang mempunyai nilai KHM in vitro ≤ 2 µg/mL. 
Kata kunci : MDR, antibiotik, Garcinia mangostana L.
 
ABSTRACT 
Introduction: In Indonesia, the most commom uropatogen E. coli resistance has been to ampicillin (91.9%), ciprofloxacin (83.7%) and cefixime (67.6%). 
α-mangostin, a chemical compound, has been developed as a new antibiotics isolaated from herbal Garcinia mangostana L, but its effectiveness against 
multiresistant uropathogenic E. Coli has not been established. Objective: This study examined the effect of α-mangostin on growth of multiresistant E. 
coli 
Methods: α-mangostin Treatment of E. coli uropatogen bacteria was administered in vitro, using 14 levels of concentration 14; 28,13; 56.25; 112.5; 
225; And 450 μg/mL with 4 times replication at each concentration. The antibacterial activity of α-mangostin was determined by evaluating bacterial 
growth at each concentration using the indirect method by sample absorbance reading. The Samples of uropatogen of E. coli treated with various doses of 
α-mangostin were incubated for 18-20 hours and then subjected to the absorbance reading using a UV-Vis spectrophotometer λ 625 nm. 
Results: Minimum inhibitory concentration (MIC) in this study was 450 mg/mL. Based on linear regression (STATA 13.1) relationship between 
α-mangostin concentrations and bacterial growth inhibition activity showed 0.0001 <0.05 showing that all concentrations of α-mangostin simultaneously 
had a significant effect on the growth of uropathogenic E. coli. 
Conclusion: α-mangostin has not been effective to inhibit the growth of multiresistent uropathogentic E. coli due to a relatively high MIC (450 mcg/mL). 
a Potentially relevant activity in the clinical setting will occur if the value of the MIC of a substance in vitro <100 μg /mL. Even the pharmaceutical 
industry prefers the development of antibiotics with in vitro MIC value of ≤ 2 μg/mL.
Keywords: MDR, antibiotics, Garcinia mangostana L. 
INTRODUCTION
The most common extraintestinal infections 
caused by the bacteria of  Escherichia coli (E. coli) 
has been urinary tract infection (UTI). This disease 
occurs at least 25-35% adul women during their life 
(Alhashash et al., 2013). 
 The incidence of  multi-drug-resistant 
uropathogenic Escherichia coli has been reported in 
Nepal (Baral et al., 2012) represeting 38.2% total isolates 
of  patient with UTI. Moreover, 55.2% uropathogenic E. 
coli was detected toproduce Extended Spectrum Beta 
Lactamase (ESBL). Another study stated that the most 
Copyright @ 2017 Authors. This is an open access article distributed under the terms of  the Creative Commons Attribution-NonCommercial-
ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-nc-sa/4.0/), which permits unrestricted non-commercial 
use, distribution, and reproduction in any medium, provided the original author and source are properly cited.
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(Sukandar, 2009). Meanwhile, the incidence of  multi 
drug resistance of  E. coli has become a global problem 
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common E. coli resistece was to co-trimoxazole (86%), 
amoxicillin (76%), class of  cephalosporins (53.75% 
- 70%), and followed by the fluoroquinolone group 
(52.5% - 57.5%) (Ihsan et al., 2014). Meanwhile, broad-
spectrum antibiotics such as amoxicillin clavulanate, 
flurokuinolon, and cephalosporin have been avoided 
due to the risk of  resistance. In Indonesia, the most 
commom resistance in uropatogen E. coli is resistance 
to ampicillin (91.9%), followed by ciprofloxacin (83.7%) 
and cefixime (67.6%). The resistance is caused by the 
irrational use of  antibiotics (Khalilullah et al., 2011). 
The multiresistant uropathogenic E. Coli 
incidence requires us to look for alternative treatment. 
Despite efforts to optimize the parameters of  the 
available pharmacokinetics/pharmacodynamics of  
each has been done, but optimizing the parameters PK/
PD is not completely reduce the incidence of  antibiotic 
resistance (Gloede et al., 2010). Other efforts that can 
be done is infection therapy using herbal medicine or 
chemical isolates from herbal ingredients. Mangosteen 
(Garcinia mangostana L.) Are found in Indonesia, 
some active isolates were tested possess antibacterial 
activity. Mangosteen extracts are reported to have 
pharmacological activity as anti-inflammatory, cytotoxic 
agents, antitumor, allergy, antioxidant, antiviral, and 
antibacterial. Primary isolates α-mangostin showed 
a fairly high cytotoxic activity against bacteria (Al 
Massarani et al., 2013). The antibacterial activity of  
α-mangostin is bactericidal with the mechanism of  
bacteria out (Koh et al., 2013). 
Several studies have demonstrated the 
effectiveness of  alpha-mangostin against Gram + 
especially Staphylococcus aureus, Leptospira and 
Mycobacterium tuberculosis (Seesom et al., 2013). 
Another study of  Bhat and Daihan (2013) showed a 
moderate susceptibility of  bacteria to xanthones in the 
extract of  Garcinia mangostana L. is Staphylococcus 
aureus, Streptococcus pyogenes, Bacilus subtilis and 
Escherichia coli. But among the four strains tested, 
Streptococcus pyogenes was the most susceptible to the 
extract of  Garcinia mangostana L. The antibacterial 
activity of  α-mangostin against multidrug resistat 
uropathogenic E. coli has not been proven. Therefore, 
this study aimed to determine antibacterial activity of  
α-mangostin against multiresistant drug uropathogenic 
E. coli in vitro. 
METHODS
A. Population and sample research 
The study population was uropathogenic E. coli 
isolated from patients with UTIs in Muhammadiyah 
Roemani hospital of  Semarang. The multidrug resistent 
uropathogenic E. coli samples were confirmed with a 
series of  biochemical tests 
B. Uropathogenic biochemical test of multidrug 
Resistent uropathogenic E. coli 
The isolates obtained from UTI patients 
were grown in MacConkey media containing Eosin 
Methylene Blue (EMB), before gram staining. A series 
action undermines the integrity of  bacterial cytoplasmic 
membrane so that the components of  intracellular 
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of  biochemical tests were performed to idetify the 
isolate. The series of  biochemical test materials included 
IMViC (Indol test tube, Methyl red, Voges proskaur, 
and Citrate). Having idetified uropathogenic E. coli, 
the pattern of  resistance were determined using media 
Mueller Hinton Agar (MHA, Merck). The Antibiotics 
used to assess uropathogenic resistance patterns of  E. 
coli were amoxicillin, erythromycin, cotrimoxazole and 
ciprofloxacin. The multidrug Uropathogenic resistet E. 
coli were then used to test α-mangostin active substance 
(purity ≥ 98%, Sigma-Aldrich) that was dissolved in 
methanol solution(Merck). 
C. Test the effectiveness of α-mangostin against E. 
coli MDR uropathogenic E. coli 
The density of  the bacterial suspension for 
determinig the effectiveness of  alpha mangostin 
refers to the standard as described by Matuschek et al. 
(2013) suggesting a minimum density of  the bacterial 
suspension used in the test of  minimum inhibitory 
concentration ( 5 x 10 5 CFU/mL). 
The effectiveness of  alpha-mangostin against 
E. coli bacteria uropatogen was evaluated with broth 
dilution method using a series of  specific levels of  alpha-
mangostin in broth or liquid media (MHB) (Figure 1). 
The level range was as described by Al Massarani et 
al. (2013), who reported that alpha activity mangostin 
dimetilsulfoxide diluted with dimethylsulfoxide 
(DMSO) for E. coli in the form of  IC50 values of  v> 
200 µM (equivalent to 82.09 mg/mL). In addition to the 
use of  a serial level, one tube without alpha mangostin 
(positive control) was used as a control of  bacterial 
growth and a negative control tube (sterile bacterial 
media and alfa mangostin without bacteria) as a sterility 
control.     
Figure 1. Schematic flow of  treatment A, B, C, D, 
E, and F in each group of  E. coli bacteria using different 
concentrations of  alpha mangostin. (A) 450.0 µg/mL, 
(B) 225.0 µg/mL, (C) 112.5 µg/mL, (D) 56.2 µg/mL, 
(E) 23. 1 µg/mL, dan (E) 11. 5 µg/mL, for control K 
(+) containing media uropathogen MHB and E. coli 
bacteria, as well as K (-) alpha mangostin containing 
6.75 µg/and MHB media were used. Each treatment 
was tested with 4 repetitions. 
The antibacterial activity of  alpha mangostin was 
measured by observing the growth or death of  bacteria 
at each concentration. The growth or death of  bacteria 
were tested using the indirect method, absorbance 
readings using UV-Vis λ 625 nm (wavelength readings 
McFarland standard). Samples or uropathogen of  E. 
coli treated with various doses of  alpha-mangostin 
were incubated for 18-20 hours. 
D.  Statistical analysis 
Absorbance in each treatment group was 
compared with that of  positive and negative control 
group. To analyze the relationship between the 
concentration of  alpha mangostin and the growth of  
uropathogenic E. coli, regression analysis test was 
performed using STATA 13.1. 
RESULTS 
a. Biochemistry test of Multidrug resistant 
Uropathogenic of E. coli 
Uropatogen E. coli is a Gram-negative growing 
in the agar media of  Mac Conkey. E. coli is a strong 
lactose fermenter, so that the production of  acid 
produced is enough to precipitate bile salts. Colonies 
produced by E. coli on MacConkey agar medium was 
pink with a halo effect around the colony. For bacteria 
that can not perform lactose fermentation, the Gram 
bacteria colony - growing in MacConkey media will 
be transparent or yellowish (Allen, 2013). 
The second identification test using EMB agar 
medium, colonies of  purple E. coli and have a metallic 
green color luminescence characteristics. Agar media of  
EMB was used to distinguish E. coli lactose fermentant 
from Enterobacter aerogenes (Oxoid, 2010). biochemical 
tests, ie indol test, methyl red, proskaur voges, and citrate 
were done for confirmation. The results of  biochemical 
tests on samples of  the uropathogenic E. coli isolates 
of  patients with UTI is shown in table 1: 
Table 1.  Results of biochemical test on the samples of 
uropathogenic E. Coli 
To get Multidrug resistant uropathogenic E. coli, 
the bacteria confirmed by chemical were subjected 
to sensitivity test to assess the patterns of  resistance. 
Multiresistant bacteria are bacteria resistant to three or 
more antibiotics. Samples of  uropathogenic E. coli used 
uropatogen included antibiotics multiresistant bacteria. 
The uropatogenic samples of  E. coli were resistant to 
amoxicillin, erythromycin and cotrimoxazole (Satari 
and Mieke, 2012). The Interpretation of  sensitivity test 
results is presented in table 2 below: 
b. Minimum Inhibitory Assay Results of α 
-Mangostin against Uropathogenic E. coli 
Minimal inhibitory concentration assessment 
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was performed by broth dilution method using a 
Mueller Hinton Broth (MHB) media -mangostin α 
concentration range 14-450 µg/mL. the absorbtion 
after the treatment on uropathogenic E.coli is shown 
as follows; 
Table 3. Mean ± SD difference (decrease/increase) in 
absorbance after treatment α - mangostin on 
uropathogen E. coli in MHB media
* The absorbance was determined from the 
absorbance value of  the treatment after incubation 
minus the absorbance value of  the treatment prior to 
incubation. The brackets () shows a negative value, 
meaning that there was a decrease in treatment 
absorbance (decrease in the number of bacteria), whereas 
increased absorbance means there is an increase in the 
number of  bacteria after incubation. 
The results in Table 3 showed that the 
concentration of  α-mangostin 450 µg /ml showed 
a decrease in the number of  bacteria sindicated 
from from a decrease in absorbance of  the solution. 
For -mangostin α concentrations of  14-225 mg/mL 
there was an increased absorbance or an increase in 
the number of  bacteria after incubation. It can be 
concluded that the minimal inhibitory concentration 
of  α-mangostin against uropathogenic - E. coli was 450 
µg /mL. Furthermore, α-mangostin at concentrations 
of  14-225 µg/mL showed no bacterial growth inhibition 
against uropathogenic E. coli. 
The control group was used as control of  the 
media and control the growth of  uropathogenic E. coli. 
the control positive group showed bacterial growth, 
whereas negative control showed bacterial growth. 
Results of  negative controls showed that α-mangostin 
and media used was sterile. Positive control results 
indicated that uropathogenic E. coli can grow on the 
medium. 
c. Statistic analysis 
The statistical analysis of  linear regression was 
applied to determie the effectiveness of  a dose of  α-
mangostin agaist E. coli. the tests were carried out by 
finding the relationship between the value of  the dose of  
α-mangostin and the decrease/increase in absorbance 
after incubation. The analysis was performed using 
STATA 13.1 and the results is shown in Figure 2: 
 The lowest absorbance value was found at 
concentrations of  450 µg/ml. The coefficient of  
determination ((R2) was 0.6115 = 61.15%. This 
indicates that the sample absorbance variable variation 
can be explained by variable concentrations of  α-
Table 2.  Results of uropathogenic E. coli sensitivity test along with a reference standards (EUCAST 2015 and Cockerill 
et al., 2012) 
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mangostin was 61.15%. The equation obtained by 
the regression line was y = - 0.0009x + 0.1987. The 
value of  y is predicted log of  the number of  bacterial 
colonies of  uropathogenic E. coli (UPEC), while the 
value of  x is the concentration of  α-mangostin. F test 
value 0.0001 <0.05 stated that all concentrations of  α-
mangostin simultaneously have a significant effect on 
the absorbance, in other words they have an effect on 
the growth of  uropathogenic E. coli. 
DISCUSSION 
the treatment with a differet levels of  
concentration of  α-mangostin, showed that the 
minimum inhibitory concentration of  α-mangostin by 
evaluating the turbidity in the test tube after incubation 
for 18-20 hours and at 370 C could not be done. This 
is due to the fact that turbidity can also be caused by 
α-mangostin, not only due to the presence of  bacteria. 
The minimum inhibitory concetration were determined 
by calculating the difference in absorbance before and 
after 18-20 hours incubatio at 37 0 C. 
The Minimum inhibitory cocentration againts 
uropathogenic E. coli was established at 450 µ g/ml. 
This showed a negative result or decreased absorbance 
of  the treated solution compared to absorbance prior 
to incubation. In α- mangostin with a concentration 
14 to 225 µg/mL showed an increase i absorbance after 
incubation incicating no bacterial growth ihibition 
againts uropathogeic E. coli. 
Alfa xanthon mangostin is derivataives 
compounds found in the peel of  the mangosteen fruit 
(Garcinia mangostana L) and has the IUPAC name 
1,3,6-trihydroxy-7-methoxy-2,8-bis (methyl-2-butenyl) 
-9H-xanten- 9-on (MY Ibrahim et al., 2014). Xanthon is 
the main compound of  Garcinia mangostana L., the 
widely distributed plant in Indonesia. This plant belongs 
to the family Clusiaceae. The optimum temperature 
for Garcinia mangostana L. is 25-350 C (Brunner and 
Payan, 2011). Some of  the pharmacological activities 
associated with α- mangostin include antioxidants, anti-
inflammatory, anticancer, hypo-allergenic, antiviral, 
antibacterial, antifungal, and antimalarial activity. Other 
Xanthones such as gamma mangostin and xanthon 




Figure 1.  Chemical structure of  α- mangostin (MY Ibrahim 
et al., 2014) 
The minimum inhibitory levels were obtained 
by the study conducted by Zou et al. (2013) which 
showig that the α- mangostin less effective in killing 
gram-negative bacteria with the minimum inhibitory 
concentration >200 µg/mL. Uropathogenic Escherichia 
coli belongs to the gram-negative bacteria with outer 
cell membrane composed of  lipopolysaccharide. This 
lipopolysaccharide serves as a non permeable barrier 
that is not permeable to hydrophobic molecules. Test 
Figure 2. linear regression relationship between the dose of  α-mangostin and absorbance values * 
* The absorbance is determined by evaluating the absorbance value of  the treatment after incubation 
minus the absorbance value of  the treatment prior to incubation. 
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substances in this treatment, α- mangostin are oe of  
the xanthon derivatives composed of  hydrophobic 
molecules. This causes reduction in the antibacterial 
activity of  α- mangostin against bacteria. Alpha 
mangostin was reported to be more effective against 
gram-positive bacteria than gram-negative (Koh et al., 
2013). Gram-positive bacteria susceptible to alpha 
mangostin include Streptococcus mutans, the cause 
of  dental caries (Nguyen and Marquis, 2011). 
Other studies related to α- mangostin as 
antibacterial stated that α- mangostin potently inhibit 
the growth of  methicillin-resistant Staphylococcus 
aureus (MRSA). Koh et al. (2013) states that the α- 
mangostin bactericidal activity against in vitro can 
quickly reduce the bacterial colony to 103 5 minutes. 
Alpha mangostin damage the integrity of  the 
cytoplasmic membrane of  bacteria rapidly, causing 
damage in intracellular component bacteria and cause 
the bacteria to die. A study conducted by Seesom et 
al. (2013) stated that α- mangostin has the potential 
to inhibit the growth of  Mycobacterium tuberculosis. 
Other studies on antibacterial activity of  mangostin was 
coducted by Zou et al. (2013) stating that the test on the 
effect of  mangostin against Pseudomonas aeruginosa 
and Klebsiella pneumoniae resulted in MIC of  40-50 
µg/mL. The studies on effect of  α- mangostin against 
several bacteria including Escherichia coli have also 
been carried out by Al Massarani et al. in 2013 resulting 
in E. coli IC 50 >200 µg/mL. 
Previous studies showed that α- mangostin has 
effective antimicrobial activity shown by a low the 
minimum inhibitory concentration, the rapid bactericidal 
activity, and the ability to minimize the occurrence of  
bacterial resistance. However, α- mangostin did not 
show a sufficient selectivity between of  bacterial and 
mammalian cell membranes. Xanthon hydrophobic 
properties contained in the α- mangostin provides a 
strong driving force for fat solution to penetrate the 
of  eukaryotic and prokaryotic membrane. However, 
some studies have reported that this can be overcome by 
modifying smaller molecules to be specific to bacterial 
cell membranes (Zou et al., 2013). 
The high value of  the MIC in this study showed 
lack of  effectiveness of  alpha-mangostin against E. 
Multidrug uropathogenic E. coli. The high value of  α- 
mangostin MIC resulted in consumption in the form 
of  mangosteen peel extract or pure compound in very 
large quantities. This will affect the toxicity of  the 
alpha mangostin in the human body. A study showed 
that the oral administration did not obtain a complete 
concentration profile due to the low bioavailability of  
α- angostin. Chitchumroonchokchai et al. (2012) stated 
that 60 ml of  mangosteen juice provides ± 3.07 mmol/
L α- mangostin. α- mangostin maximum levels in the 
blood is reached at 3.7 ± 2.4 hours with maximum 
concentration on one subject of  450 nmol/L, equivalent 
to the levels of  0.18 µ g/mL. This suggests that to get 
the levels of  225 µg/mL of  blood requires mangosteen 
juice as much as 7500 ml. 
According to Ramaiya et al. (2012) α- mangostin 
when administered in cotton seed oil in rats with an 
equivalent dose of  615 mg in a 90 kg adult human, 
reaches a maximum plasma concentration of  1.300 
nmol/L and are detected up to 24 hours. In -mangostin 
α administration in rats through the veins is stated in 
the study of  Li et al. (2011) that the disposition of  α- 
mangostin in rat plasma is biphasic, divided into fast 
distribution and slow elimination phase. The half-life 
of  the distribution phase is 3 minutes and the terminal 
elimination phase is 3.5 hours. It indicates a high bond 
between α- mangostin with tissue. 
In this study, the determination of  the activity 
of  α-mangostin was conducted to merely evaluate 
the value of  the minimum inhibitory concentration. 
Determination of  minimal bactericidal acticity was 
not conducted. Some literature state that potentially 
relevant activity in the clinical setting will occur if  the 
value of  MCI <100 µg/mL. Even the pharmaceutical 
industry prefers the development of  antibiotics with 
≤ 2 µg/mL. Minimum bactericidal activity is greater 
than MIC value, because the KHM value obtained 
in this study was 450 µg/mL (or greater than 100 µg/
mL), then the MIC was not determined (Sanchez and 
Kouznetsov, 2010; Levison and Levison, 2009). 
The antibacterial activity of  alpha mangostin, 
especially against Gram negative bacteria requires 
further studied. The study of  synergism with some 
antibiotics also did not show effective results. The 
combination of  alpha mangostin with ampicillin, 
penicillin G, tetracycline and streptomycin did not 
showed effectiveness against Gram - (E. coli) and 
Gram + (S. aureus) (NHS Ibrahim et al., 2014). The 
crude extract activity of  either the ethanol or water 
fraction of  Garcinia mangostana Linn was also tested 
on several pathogenic bacteria. The results of  these 
studies suggested that the required concentration of  
MIC and MBC is quite large (4000 mg/mL to extract 
water and 2000 mg/mL ethanol extract ), to be able 
to inhibit and kill bacteria E. coli (RV Geetha et al., 
2011). 
CONCLUSION 
α- mangostin is not effective to inhibit the growth 
multi drug resistat uropahogenic E. coli multiresistant 
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uropatogen due to a relatively high MIC (450 mcg/
mLz). The antibacterial activity of  alpha mangostin, 
especially its activity against Gram negative requires 
futher studied. The study of  synergism with some 
antibiotics also did not show effective results. 
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